Cuorips (TSE:4894) Stock Based Compensation: 円62.9 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4894 Cuorips Inc TSE:4894
67 GF Score
Price 円4,170.00
GF Value 円29,092.73
Valuation Possible Value Trap
! 2 Warning Signs
View Full Analysis

What is Cuorips Stock Based Compensation?

Cuorips TSE:4894 -1.53% 67 Stock Based Compensation is 円62.9 Mil as of Mar. 2026. GuruFocus rates TSE:4894 with a GF Score™ of 67/100 and a GF Value™ of 円29,092.73 (Possible Value Trap). The stock has 2 warning signs investors should review.

Cuorips's Stock Based Compensation for the six months ended in Mar. 2026 was 円8.0 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 was 円62.9 Mil.

Cuorips Stock Based Compensation Related Terms

Cuorips Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for Cuorips's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cuorips Stock Based Compensation Chart

Cuorips Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Stock Based Compensation
Get a 7-Day Free Trial 0.00 -0.54 0.00 0.00 62.87

Cuorips Semi-Annual Data
Mar21 Mar22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 54.89 7.98
TSE:4894
67GF Score
Cuorips Inc TSE:4894
Stock Based Compensation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cuorips Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was 円62.9 Mil.

What does a Stock Based Compensation of 円62.9 Mil mean?
Cuorips (TSE:4894) has a Stock Based Compensation of 円62.9 Mil as of Mar. 2026. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Cuorips and its competitors.
Is Cuorips' Stock Based Compensation too high?
Cuorips' current Stock Based Compensation is 円62.9 Mil. Overall, Cuorips has a GF Score™ of 67/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Cuorips' Stock Based Compensation compare to VRTX and REGN?
Cuorips' Stock Based Compensation of 円62.9 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Biotechnology company?
A good Stock Based Compensation depends on the Biotechnology industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Cuorips and its competitors. Cuorips's current Stock Based Compensation is 円62.9 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cuorips stock overvalued right now?
Based on GuruFocus' analysis, Cuorips (TSE:4894) is currently considered Possible Value Trap. The stock's GF Value™ is 円29,092.73, compared to a current price of 円4,170.00 — trading 85.7% below its estimated fair value. The current Stock Based Compensation is 円62.9 Mil. Cuorips' overall GF Score™ is 67/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For Cuorips (TSE:4894), the current Stock Based Compensation is 円62.9 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cuorips (TSE:4894) Overvalued in 2026?

Based on GuruFocus' analysis, Cuorips stock appears to be undervalued. The current stock price of 円4,170.00 is trading 85.7% below its estimated GF Value™ of 円29,092.73. GuruFocus considers Cuorips to be Possible Value Trap.

Key valuation signals for TSE:4894:

  • Stock Based Compensation: 円62.9 Mil
  • GF Value™: 円29,092.73 vs. price of 円4,170.00 (85.7% below fair value)
  • GF Score™: 67/100 with 2 warning signs

No single metric tells the full story. See the TSE:4894 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cuorips Business Description

Address 3-11-5 Nihonbashi-Honcho, 507, Nihonbashi Life Science Building 2, Chuo-ku, Tokyo, JPN, 103-0023
Cuorips Inc is engaged in the Research, development, manufacturing, and sales of Cellular and Tissue-based Products and Cell processing products. The company is also engaged in Contract development and manufacturing services and consulting services of Cellular and Tissue-based Products and Cell processing product.
67GF Score

Get the complete analysis for TSE:4894

Stock Based Compensation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円4,170.00
Price
円29,092.73
GF Value